Tuberculosis Drug Wins Backing of European Panel

Otsuka Pharmaceutical's Deltyba would be only the second new antibiotic against the deadly disease in more than 40 years.



from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304607104579214491854484538.html?mod=pls_whats_news_us_business_f

via IFTTT